skip to main content
DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Gastrin receptor-avid peptide conjugates

Abstract

A compound for use as a therapeutic or diagnostic radiopharmaceutical includes a group capable of complexing a medically useful metal attached to a moiety which is capable of binding to a gastrin releasing peptide receptor. A method for treating a subject having a neoplastic disease includes administering to the subject an effective amount of a radiopharmaceutical having a metal chelated with a chelating group attached to a-moiety capable of binding to a gastrin releasing peptide receptor expressed on tumor cells with subsequent internalization inside of the cell. A method of forming a therapeutic or diagnostic compound includes reacting a metal synthon with a chelating group covalently linked with a moiety capable of binding a gastrin releasing peptide receptor.

Inventors:
; ; ; ;
Issue Date:
Research Org.:
Univ. of Missouri, Columbia, MO (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1175787
Patent Number(s):
7060247
Application Number:
09/847,134
Assignee:
University Of Missouri
Patent Classifications (CPCs):
C - CHEMISTRY C07 - ORGANIC CHEMISTRY C07K - PEPTIDES
C - CHEMISTRY C07 - ORGANIC CHEMISTRY C07F - ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
DOE Contract Number:  
FG02-89ER60875
Resource Type:
Patent
Country of Publication:
United States
Language:
English
Subject:
62 RADIOLOGY AND NUCLEAR MEDICINE

Citation Formats

Hoffman, Timothy J., Volkert, Wynn A., Sieckman, Gary, Smith, Charles J., and Gali, Hariprasad. Gastrin receptor-avid peptide conjugates. United States: N. p., 2006. Web.
Hoffman, Timothy J., Volkert, Wynn A., Sieckman, Gary, Smith, Charles J., & Gali, Hariprasad. Gastrin receptor-avid peptide conjugates. United States.
Hoffman, Timothy J., Volkert, Wynn A., Sieckman, Gary, Smith, Charles J., and Gali, Hariprasad. Tue . "Gastrin receptor-avid peptide conjugates". United States. https://www.osti.gov/servlets/purl/1175787.
@article{osti_1175787,
title = {Gastrin receptor-avid peptide conjugates},
author = {Hoffman, Timothy J. and Volkert, Wynn A. and Sieckman, Gary and Smith, Charles J. and Gali, Hariprasad},
abstractNote = {A compound for use as a therapeutic or diagnostic radiopharmaceutical includes a group capable of complexing a medically useful metal attached to a moiety which is capable of binding to a gastrin releasing peptide receptor. A method for treating a subject having a neoplastic disease includes administering to the subject an effective amount of a radiopharmaceutical having a metal chelated with a chelating group attached to a-moiety capable of binding to a gastrin releasing peptide receptor expressed on tumor cells with subsequent internalization inside of the cell. A method of forming a therapeutic or diagnostic compound includes reacting a metal synthon with a chelating group covalently linked with a moiety capable of binding a gastrin releasing peptide receptor.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2006},
month = {6}
}

Patent:

Save / Share:

Works referenced in this record:

Potent Gastrin-Releasing Peptide (GRP) Antagonists Derived from GRP(19-27) with a C-Terminal DPro.PSI.[CH2NH]Phe-NH2 and N-Terminal Aromatic Residues
journal, February 1994


BW2258U89: A GRP receptor antagonist which inhibits small cell lung cancer growth
journal, January 1995


Metabolic stability and tumor inhibition of bombesin/GRP receptor antagonists
journal, March 1992


Synthesis, Characterization, and Labeling with 99m Tc/ 188 Re of Peptide Conjugates Containing a Dithia-bisphosphine Chelating Agent
journal, May 2001


Chemical and physical properties of radionuclides
journal, January 1987


Radiometallated receptor-avid peptide conjugates for specific in vivo targeting of cancer cells
journal, July 2001


Vehicles, Chelators, and Radionuclides:  Choosing the “Building Blocks” of an Effective Therapeutic Radioimmunoconjugate
journal, January 1996


Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: A new gastrin releasing peptide receptor (GRPr) targeting radiopharma ceutical
journal, May 2001


Pseudononapeptide bombesin antagonists containing C-terminal Trp or Tpi
journal, March 1992


Potent bombesin antagonists with C-terminal Leu-psi(CH2-N)-Tac-NH2 or its derivatives.
journal, December 1994


Bombesin antagonists inhibit in vitro and in vivo growth of human gastric cancer and binding of bombesin to its receptors
journal, September 1994


In vitro and in vivo characterization of novel water-soluble dithio-bisphosphine 99mTc complexes
journal, October 1997


The mechanism of receptor-mediated endocytosis
journal, December 1991


Radiolabeling with technetium-99m to study high-capacity and low-capacity biochemical systems
journal, March 1995


Development of an in vitro model for assessing the in vivo stability of lanthanide chelates
journal, February 2001


BW1023U90: A new GRP receptor antagonist for small-cell lung cancer cells
journal, January 1996


Binding, internalization, and processing of bombesin by rat pancreatic acini
journal, July 1991


No carrier added preparations of ‘3 + 1’ mixed-ligand 99mTc complexes
journal, January 1998


Tumour targeting with radiolabelled macrocycle–antibody conjugates
journal, January 1990


Design and development of receptor-avid peptide conjugates for in-vivo targeting of cancer
conference, July 1999